LXRX - Lexicon Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LXRX is currently covered by 2 analysts with an average price target of $3.69. This is a potential upside of $2.46 (200%) from yesterday's end of day stock price of $1.23.

Lexicon Pharmaceuticals's activity chart (see below) currently has 53 price targets and 55 ratings on display. The stock rating distribution of LXRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.5% with an average time for these price targets to be met of 66 days.

Highest price target for LXRX is $4, Lowest price target is $4, average price target is $4.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 02-Sep-2025. First documented stock forecast 11-Oct-2013.

Currently out of the existing stock ratings of LXRX, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$4

$2.57 (179.72%)

3 months 25 days ago
(02-Sep-2025)

0/6 (0%)

$2.88 (257.14%)

Buy

$10

9 months 20 days ago
(07-Mar-2025)

0/2 (0%)

$7.55 (308.16%)

Buy

$4

$2.57 (179.72%)

$8

2 years 15 days ago
(12-Dec-2023)

4/15 (26.67%)

$2.82 (238.98%)

47

Buy

$2

$0.57 (39.86%)

4 years 10 months 28 days ago
(29-Jan-2021)

2/6 (33.33%)

$-5.91 (-74.72%)

409

Sell

4 years 10 months 28 days ago
(29-Jan-2021)

2/2 (100%)

$1.91 (23.61%)

65

Show more analysts

Please expand the browser size to see the chart

What is LXRX (Lexicon Pharmaceuticals) average time for price targets to be met?

On average it took 66 days on average for the stock forecasts to be realized with a an average price target met ratio 32.5

Which analyst has the current highest performing score on LXRX (Lexicon Pharmaceuticals) with a proven track record?

JESSICA FYE

Which analyst has the current lower performing score on LXRX (Lexicon Pharmaceuticals) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on LXRX (Lexicon Pharmaceuticals)?

Jessica Fye works at JPMORGAN and has 2 price targets and 2 ratings on LXRX

Which analyst is the currently most bullish on LXRX (Lexicon Pharmaceuticals)?

Joseph Pantginis with highest potential upside - $2.57

Which analyst is the currently most reserved on LXRX (Lexicon Pharmaceuticals)?

Stephen Willey with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?